Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 301.00
Ask: 308.00
Change: -5.00 (-1.64%)
Spread: 7.00 (2.326%)
Open: 306.00
High: 306.00
Low: 300.00
Prev. Close: 305.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate, Financing and Trading Update

24 Mar 2023 07:00

RNS Number : 0872U
Fisher (James) & Sons plc
24 March 2023
 

This announcement contains inside information

 

24 March 2023

 

James Fisher and Sons plc

 

Corporate, Financing and Trading Update

 

James Fisher and Sons plc (FSJ.L) ("James Fisher", the "Group" or the "Company"), the leading provider of marine services is today providing a corporate, financing and trading update, the highlights of which are as follows:

 

· Publication of FY 2022 financial results to be delayed from 28 March 2023 to 28 April 2023

 

· This additional time provides an opportunity for the Group to complete the previously announced discussions in relation to its existing debt facilities

 

· The Group is also required to resolve certain technical restrictions, relating to the JFN Disposal, which have been waived through to 28 April 2023

 

· Audit process ongoing for FY 2022 - as a result, underlying operating profit from continuing operations now expected to be broadly in line with FY 2021

 

· Trading in first two months of 2023 was in line with the Group's expectations and ahead of the same period in the prior year

 

Corporate and Financing Update

 

As previously announced, the Group commenced discussions with its lending banks earlier this year regarding its existing debt facilities, which have maturity dates ranging from October 2023 to September 2024.

 

On 6 March 2023, the Group announced the sale of James Fisher Nuclear Holdings Limited ("JFN") and related properties (the "JFN Disposal"). As per the 6 March 2023 announcement, under the terms of the JFN Disposal agreement, several legacy parent company guarantees supporting the obligations of JFN were retained by James Fisher (the "PCGs"). The retention of the PCGs required consent under the Group's debt facilities prior to the sale of JFN, which was not obtained at the time. Following discussions, all lenders under the debt facilities have agreed waivers in respect of the PCGs until 28 April 2023.

 

The Group is grateful for the lenders' constructive approach and has accelerated engagement with them to seek a permanent solution in relation to the PCGs and to address its debt facilities by end of April 2023. 

 

The Group intends to publish its financial results for FY 2022 on 28 April 2023.

 

FY 2022 results

 

The audit process for FY 2022 is well-advanced, but ongoing, and remains subject to finalisation. At this stage, for the year ended 31 December 2022, the Group is expecting to report revenue from continuing operations of c.£475m (2021: £442.4m). Underlying operating profit from continuing operations is expected to be broadly in line with FY 2021.

 

James Fisher made good strategic progress over the second half of 2022 and in early 2023, divesting non-core businesses, as well as selling a significant fixed asset. The three business sales completed in December 2022 generated gross proceeds of c.£18.4m and net bank borrowings at 31 December 2022 were c.£135m. The sale of the Swordfish Dive Support Vessel, which was announced in December 2022, completed in January 2023, with cash proceeds of c.£20m now received.

 

Important changes have been made at the senior management level across several of our businesses. This will improve financial and performance accountability, as well as promote energetic and disciplined leaders from inside the organisation who have a demonstrable track record in achieving operational targets. Additionally, in order to simplify the Group further, from 1 January 2023 the Company has been reorganised into three new divisions which reflect our customer verticals, namely Energy, Defence and Maritime Transport.

 

Current trading update

 

The Group has made an encouraging start to 2023, with performance across January and February (the "Period") demonstrating continued progress, in line with the Board's expectations.

 

Group revenue in the Period saw strong year-on-year growth, with divisional trends similar to those seen towards the end of 2022. On both a continuing operations and total Group basis (including discontinued operations), James Fisher generated a small underlying operating profit in the Period, compared with a loss in the prior year.

 

The Group's net debt position is in line with management's expectations, benefiting from the receipt of Swordfish proceeds, and the Board expects the Group to continue to de-lever.

 

Whilst the economic climate more generally remains challenging, the Group has made clear strategic and financial progress over the last few months. With the benefit of a more focused portfolio and reinvigorated strategy, the Board is confident that the Group can carry forward this momentum through 2023, driving further financial and operational improvement.

 

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

01229 615400

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELEDDEDSEFD
Date   Source Headline
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20202:51 pmRNSDisclosure of Rights Attached to Equity Shares
30th Apr 20202:49 pmRNSResult of AGM
30th Apr 20207:00 amRNSAGM trading statement & Covid-19 update
21st Apr 20209:00 amRNSHolding(s) in Company
15th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 202010:20 amRNSDirector/PDMR Shareholding
1st Apr 20204:35 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSAnnual General Meeting and COVID-19
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSCovid-19 Update
20th Mar 20205:30 pmRNSAnnual Report and Accounts posted
20th Mar 20204:45 pmRNSDirector/PDMR Shareholding
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSDirectorate Change
18th Mar 202012:02 pmRNSPrice Monitoring Extension
18th Mar 202010:21 amRNSFinal dividend payment date
17th Mar 20203:57 pmRNSDirector/PDMR Shareholding
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20204:41 pmRNSSecond Price Monitoring Extn
27th Feb 20204:36 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSFinal Results for the year ended 31 December 2019
21st Feb 20207:00 amRNSFour year contract extension worth £35m
13th Feb 202012:51 pmRNSDirector Shareholding Update
16th Jan 20203:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jan 202012:07 pmRNSSecond Price Monitoring Extn
9th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202011:06 amRNSDirector/PDMR Shareholding
2nd Jan 202011:19 amRNSTotal Voting Rights
6th Dec 20199:35 amRNSTotal Voting Rights and Share Capital
28th Nov 20197:00 amRNSTrading Update
5th Nov 20191:29 pmRNSNotice of cyber security incident
2nd Oct 201911:39 amRNSTotal Voting Rights and Share Capital
1st Oct 20197:00 amRNSCONFIRMATION OF APPOINTMENT OF CEO
27th Sep 20197:00 amRNSSubmarine Rescue System contract
4th Sep 20192:38 pmRNSTotal Voting Rights
28th Aug 20197:00 amRNSHalf year results
7th Aug 20197:00 amRNSAcquisition of SM Continental S.A.
16th Jul 20197:00 amRNSContract Wins
5th Jul 20197:00 amRNSAppointment of new Chief Executive Officer
1st Jul 20199:49 amRNSTotal Voting Rights
19th Jun 201911:13 amRNSBLOCK LISTING SIX MONTHLY RETURN
10th Jun 20197:00 amRNSAdditional Listing
2nd May 20194:20 pmRNSResult of AGM
2nd May 20197:00 amRNSTrading Update & AGM Statement
26th Apr 20191:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.